Deferoxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe (III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
Product Specifications
CAS Number
[70-51-9]
Product Name Alternative
Deferoxamine B; Deferriferrioxamine B; Deferrioxamine
UNSPSC
12352211
Hazard Statement
H315, H319, H320
Target
Akt; Apoptosis; Autophagy; HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/deferoxamine.html
Purity
99.76
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : < 0.1 mg/mL (ultrasonic)
Smiles
O=C(N(CCCCCN)O)CCC(NCCCCCN(C(CCC(NCCCCCN(C(C)=O)O)=O)=O)O)=O
Molecular Formula
C25H48N6O8
Molecular Weight
560.68
Precautions
H315, H319, H320
References & Citations
[1]Duscher D, et al. Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing. Plast Reconstr Surg. 2017 Mar;139 (3) :695e-706e. |[2]Dongiovanni P, et al. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol. 2008 Mar;172 (3) :738-47.|[3]Wang G, et al. In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrow. Environ Toxicol Pharmacol. 2017 Jan;49:58-64. |[4]Wu Y, et al. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int. 2010 Oct;57 (3) :198-205.|[5]Bellotti D, et al. Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator. Molecules. 2021 May 28;26 (11) :3255.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
ACS Chem Biol. 2022 Dec 16;17 (12) :3389-3406.|ACS Nano. 2024 Jul 2;18 (26) :16790-16807.|ACS Nano. 2025 Jun 10;19 (22) :21105-21117.|Acta Pharm Sin B. 2023 Oct;13 (10) :4318-4336.|Acta Pharm Sin B. 2025 Apr;15 (4) :2095-2113.|Acta Pharm Sin B. 2025 Jul;15 (7) :3788-3804.|Adv Mater. 2025 Jun 10:e2504829.|Adv Sci (Weinh) . 2023 May;10 (15) :e2206007.|Adv Sci (Weinh) . 2023 Sep;10 (25) :e2301088.|Adv Sci (Weinh) . 2025 Jul 26:e02052.|Adv Sci (Weinh) . 2025 Nov 6:e07384.|Aging (Albany NY) . 2024 Apr 19;16 (8) :7277-7292.|Am J Chin Med. 2024 May 3:1-19.|Am J Chin Med. 2025;53 (5) :1501-1520.|Animal Model Exp Med. 2025 Jan 23.|Antioxidants (Basel) . 2023 Dec 15;12 (12) :2119.|Apoptosis. 2024 Oct;29 (9-10) :1810-1823.|Autophagy. 2025 Aug 18:1-16.|Biochem Biophys Res Commun. 2022 May 21;605:111-118.|Biochem Biophys Res Commun. 2025 Dec 15:792:152981.|Biochim Biophys Acta Mol Basis Dis. 2024 Dec 30:167645.|Biol Direct. 2024 Nov 11;19 (1) :110.|Biol Direct. 2025 Oct 1;20 (1) :100.|Biomed Pharmacother. 2024 Aug 15:179:117309.|Biomed Pharmacother. 2024 May 10:175:116727.|Biomed Pharmacother. 2024 May:174:116542.|bioRxiv. 2025 March 18.|Bone Res. 2024 Aug 27;12 (1) :47.|Cancer Chemother Pharmacol. 2024 Dec 11;95 (1) :3.|Cancer Lett. 2024 May 1:589:216811.|Cancer Sci. 2025 Aug;116 (8) :2256-2269.|Carbohydr Polym. 2025 Feb 1.|Cell Death Differ. 2025 Mar 25.|Cell Death Dis. 2022 Dec 24;13 (12) :1070.|Cell Death Dis. 2023 Mar 25;14 (3) :211.|Cell Death Dis. 2023 Nov 25;14 (11) :767.|Cell Death Dis. 2024 Mar 1;15 (3) :181.|Cell Death Discov. 2023 Nov 18;9 (1) :419.|Cell Death Discov. 2024 Aug 12;10 (1) :360.|Cell Discov. 2025 Oct 7;11 (1) :81.|Cell Rep Med. 2025 Sep 25:102371.|Cell Rep. 2025 Aug 21;44 (9) :116186.|Cell Rep. 2025 Nov 25;44 (11) :116563.|Cell Signal. 2025 Nov:135:112024.|Chem Biol Interact. 2024 Dec 31:111368.|Chemosphere. 2024 Jul 16:142885.|Clin Transl Med. 2023 Dec;13 (12) :e1494.|Diabet Med. 2023 Jul;40 (7) :e15031.|Ecotoxicol Environ Saf. 2025 Sep 15:303:119045.|Environ Pollut. 2023 Oct 15:335:122278.|Environ Sci Technol. 2025 Oct 28;59 (42) :22423-22438.|Eur J Pharmacol. 2023 Apr 5:944:175516.|Eur J Pharmacol. 2023 Mar 15:943:175569.|Eur J Pharmacol. 2025 Jun 5:996:177424.|Exp Cell Res. 2024 Aug 28:114222.|Exp Eye Res. 2025 Oct:259:110576.|Exp Mol Med. 2025 Nov;57 (11) :2629-2642.|FASEB J. 2023 Jun;37 (6) :e22992.|FASEB J. 2025 Apr 15;39 (7) :e70488.|Free Radic Biol Med. 2023 Apr:199:67-80.|Free Radic Biol Med. 2023 Nov 1:208:348-360.|Free Radic Biol Med. 2023 Sep:206:143-161.|Free Radic Biol Med. 2024 Jul 20:S0891-5849 (24) 00565-3.|Free Radic Biol Med. 2025 Feb 1:227:233-245.|Free Radic Biol Med. 2025 Oct 27:S0891-5849 (25) 01318-8.|Front Pharmacol. 2024 Oct 17:15:1469180.|Immunobiology. 2025 Oct 3;230 (6) :153125.|Int Immunopharmacol. 2024 Nov 13;143 (Pt 3) :113617.|Int Immunopharmacol. 2024 Nov 14;143 (Pt 3) :113614.|Int Immunopharmacol. 2025 May 12:158:114827.|Int J Biol Macromol. 2024 Jul 15:133899.|Int J Biol Sci. 2024 Aug 6;20 (11) :4222-4237.|Int J Mol Sci. 2022 Dec 23;24 (1) :229.|Int J Mol Sci. 2023 Nov 17;24 (22) :16467.|Int J Pharm. 2024 Aug 12:124582.|J Adv Res. 2024 May 24:S2090-1232 (24) 00216-9.|J Adv Res. 2025 Aug:74:589-607.|J Adv Res. 2025 Feb 8:S2090-1232 (25) 00107-9.|J Agric Food Chem. 2022 May 25;70 (20) :6213-6223.|J Agric Food Chem. 2023 Nov 1;71 (43) :16310-16322.|J Appl Toxicol. 2025 Aug;45 (8) :1637-1648.|J Biochem Mol Toxicol. 2024 Apr;38 (4) :e23683.|J Cell Mol Med. 2024 Apr;28 (8) |J Control Release. 2025 Nov 20:389:114450.|J Ethnopharmacol. 2025 Apr 30:119912.|J Exp Clin Cancer Res. 2023 May 19;42 (1) :127.|J Hazard Mater. 2024 Dec 5:480:135952.|J Hazard Mater. 2025 Jul 28:496:139376.|J Immunother Cancer. 2024 Nov 24;12 (11) :e009805.|J Inorg Biochem. 2025 Nov:272:113006.|J Invest Surg. 2025 Dec;38 (1) :2535522.|J Mol Histol. 2025 Jul 31;56 (4) :245.|J Nat Med. 2024 Jun;78 (3) :618-632.|J Neurochem. 2025 Oct;169 (10) :e70246.|J Transl Med. 2025 Feb 28;23 (1) :247.|Kaohsiung J Med Sci. 2023 Jul;39 (7) :699-709.|Liver Int. 2020 Jun;40 (6) :1378-1394.|Liver Int. 2022 Dec;42 (12) :2889-2899.|Mater Today Bio. 2025 Nov 13:35:102547.|Mater Today Phys. 2023 Aug, 36, 101150.|MedComm. 2024 Apr 4;5 (4) :e520.|Mol Carcinog. 2023 Aug;62 (8) :1119-1135.|Mol Cell Biochem. 2025 Jul;480 (7) :4265-4281.|Mol Med Rep. 2026 Jan;33 (1) :24.|Mol Neurobiol. 2025 Apr;62 (4) :4055-4075.|Mol Nutr Food Res. 2024 Apr;68 (7) :e2300343.|Nano Res. 2025 Oct.|Nat Aging. 2025 Jul;5 (7) :1295-1316.|Nat Commun. 2025 Apr 1;16 (1) :3131.|NPJ Precis Oncol. 2024 Aug 21;8 (1) :183.|Oncol Rep. 2023 Jan;49 (1) :16.|Oncol Rep. 2025 Dec;54 (6) :159.|Parasit Vectors. 2023 Nov 16;16 (1) :421.|Phytomedicine. 2024 Dec:135:156139.|Phytomedicine. 2025 Apr 24:142:156804.|Phytomedicine. 2025 Nov 22:150:157584.|Phytomedicine. 2025 Sep 23:148:157326.|PLoS One. 2025 May 22;20 (5) :e0322746.|Poult Sci. 2025 Apr 16;104 (8) :105169. |Redox Biol. 2024 Aug 26:76:103328.|Redox Biol. 2024 Jun:72:103157.|Redox Biol. 2024 Sep:75:103270.|Redox Biol. 2025 May:82:103579.|Redox Biol. 2025 May:82:103597.|Redox Rep. 2025 Dec;30 (1) :2588086.|Res Sq. 2024 Oct 27.|Res Sq. 2025 Aug 08.|Research Square Preprint. 2023 Apr 25.|Research Square Preprint. 2023 Jul 26.|Research Square Preprint. 2023 Oct 13.|Research Square Preprint. 2023 Oct 18.|Sci Rep. 2024 Jun 21;14 (1) :14307.|Sci Rep. 2025 Aug 18;15 (1) :30197.|Sci Rep. 2025 Jan 7;15 (1) :1141.|Sci Total Environ. 2024 Dec 1:954:176497.|SSRN. 2024 Jun 18.|SSRN. 2024 Nov 18.|SSRN. 2025 Feb 21.|SSRN. 2025 Mar 20.|Tissue Cell. 2026 Feb:98:103221.|Water Biol Secur. 2025 Nov 13.|Wayne State University. 2025.|3 Biotech. 2025 Nov;15 (11) :374.|ACS Appl Mater Interfaces. 2018 Feb 21;10 (7) :6180-6189.|ACS Appl Mater Interfaces. 2025 Aug 13;17 (32) :45463-45478.|ACS Chem Biol. 2022 Dec 16;17 (12) :3389-3406.|Acta Pharm Sin B. 2021 Jun;11 (6) :1513-1525.|Acta Pharm Sin B. 2025 Oct 28.|Acta Pharmacol Sin. 2021 Feb;42 (2) :301-310.|Acta Pharmacol Sin. 2021 Jan;42 (1) :160-170.|Acta Pharmacol Sin. 2025 Jul;46 (7) :1974-1989.|Adv Sci (Weinh) . 2021 Mar 8;8 (10) :2004680.|Adv Sci (Weinh) . 2023 Aug;10 (22) :e2206798.|Adv Sci (Weinh) . 2025 Jan 31:e2408845.|Adv Sci (Weinh) . 2025 Nov 7:e18323.|Anal Chim Acta. 2021 Sep 22:1179:338853.|Antioxidants (Basel) . 2023 Dec 19;13 (1) :4.|Antioxidants (Basel) . 2024 Jul 14;13 (7) :840.|Aquaculture. 2024 Jan 30, 579, 740203.|Arch Biochem Biophys. 2023 Aug:744:109691.|Arch Biochem Biophys. 2023 Jul 1:742:109622.|Arch Biochem Biophys. 2025 Jun:768:110366.|Bioact Mater. 2021 Nov 19;13:23-36.|Biochem Biophys Res Commun. 2019 Nov 12;519 (3) :533-539.|Biochem Biophys Res Commun. 2022 Dec 20:635:57-64.|Biochem Biophys Res Commun. 2024 May 28:710:149895.|Biochem Pharmacol. 2021 Apr:186:114436.|Biochem Pharmacol. 2024 May:223:116194.|Biochem Pharmacol. 2025 Jan 18:116763.|Biochem Pharmacol. 2025 Jan 29:116788.|Biochim Biophys Acta Mol Basis Dis. 2025 Jun 17;1871 (7) :167955.|bioRxiv. 2020 Dec 14.|bioRxiv. 2023 Feb 8.|Br J Pharmacol. 2024 Dec;181 (23) :4822-4844.|Br J Pharmacol. 2024 Oct;181 (20) :4067-4084.|Brain Res Bull. 2023 Jan:192:192-202.|Cancer Cell Int. 2024 Jun 3;24 (1) :194.|Cancer Lett. 2024 Apr 10:587:216732.|Cancer Med. 2024 Oct;13 (19) :e70271.|Cancer Nanotechnol. 2023 Oct 21.|Cancers (Basel) . 2022 Jan 11;14 (2) :345.|Carbohydr Polym. 2025 Mar 1:351:123123.|Cell Biol Int. 2024 Oct;48 (10) :1559-1572.|Cell Commun Signal. 2022 Aug 17;20 (1) :124.|Cell Death Differ. 2025 Jun;32 (6) :1071-1085.|Cell Death Dis. 2019 Oct 7;10 (10) :755.|Cell Death Dis. 2020 Mar 13;11 (3) :183.|Cell Death Dis. 2021 Apr 30;12 (5) :426.|Cell Death Dis. 2021 May 19;12 (6) :511.|Cell Death Dis. 2022 Jul 28;13 (7) :653.|Cell Death Dis. 2022 Jul 4;13 (7) :579.|Cell Death Dis. 2023 Jan 12;14 (1) :22.|Cell Death Dis. 2023 Sep 4;14 (9) :588.|Cell Death Dis. 2025 May 19;16 (1) :403.|Cell Death Dis. 2019 Apr 15;10 (5) :331.|Cell Death Discov. 2022 Apr 21;8 (1) :217.|Cell Death Discov. 2022 Mar 22;8 (1) :127.|Cell Death Discov. 2024 Jan 17;10 (1) :34.|Cell Death Discov. 2025 Feb 21;11 (1) :71.|Cell Mol Life Sci. 2022 Jul 4;79 (7) :394.|Cell Mol Life Sci. 2023 May 20;80 (6) :159.|Cell Rep. 2025 Sep 3;44 (9) :116240.|Cell Res. 2018 Dec;28 (12) :1171-1185. |Cell Signal. 2025 Jan 3:111583.|Chem Biol Interact. 2022 Aug 1:362:110004.|Chem Biol Interact. 2023 Oct 27:110788.|Chem Biol Interact. 2024 Feb 25:390:110870.|Chin Herb Med. 2020 Dec 8;13 (1) :105-115.|Colloids Surf B Biointerfaces. 2025 Feb 3:250:114546.|Discov Oncol. 2025 Nov 25;16 (1) :2166.|Drug Des Devel Ther. 2019 Jul 2;13:2135-2144.|EBioMedicine. 2022 Feb;76:103847.|EBioMedicine. 2022 Oct;84:104258.|Ecotoxicol Environ Saf. 2022 Dec 15:248:114333.|Ecotoxicol Environ Saf. 2023 Jul 1:259:115049.|EMBO J. 2023 Oct 16;42 (20) :e113743.|Environ Health. 2025 Nov 28, XXXX (XXX) .|Environ Pollut. 2019 Jul 30;254 (Pt A) :112937.|Environ Pollut. 2023 May 15:325:121434.|Environ Toxicol. 2021 Apr;36 (4) :520-529.|Eur J Pharmacol. 2021 May 5:898:173999.|Eur J Pharmacol. 2023 Oct 15:957:176009.|Eur J Pharmacol. 2024 Apr 15:969:176303.|FEBS J. 2022 Apr;289 (7) :1968-1983.|Fish Shellfish Immunol. 2023 Nov:142:109145.|Fish Shellfish Immunol. 2025 May 13:163:110416.|Food Chem Toxicol. 2022 Aug:166:113255.|Food Chem Toxicol. 2024 Aug 13:114926.|Food Chem Toxicol. 2025 Oct:204:115664.|Free Radic Biol Med. 2020 Nov 20;160:303-318.|Free Radic Biol Med. 2020 Nov 20;160:92-102.|Free Radic Biol Med. 2021 Jun:169:271-282.|Free Radic Biol Med. 2021 Sep:173:29-40.|Free Radic Biol Med. 2022 Aug 1:188:337-350.|Free Radic Biol Med. 2022 Feb 20:180:75-84.|Free Radic Biol Med. 2022 Feb 20:180:95-107.|Free Radic Biol Med. 2022 Nov 20;193 (Pt 1) :202-212.|Free Radic Biol Med. 2023 Dec 14:211:127-144.|Free Radic Biol Med. 2023 May 20:201:76-88.|Free Radic Biol Med. 2023 Nov 1:208:530-544.|Free Radic Biol Med. 2024 Jun 28:S0891-5849 (24) 00542-2.|Free Radic Biol Med. 2025 Aug 1:235:231-247.|Free Radic Biol Med. 2025 Aug 13:240:183-196.|Front Cell Infect Microbiol. 2022 Feb 4;12:825824.|Front Mol Biosci. 2022 Jul 22:9:952608.|Front Oncol. 2021 May 18:11:614778.|Front Oncol. 2022 May 18:12:874900.|Front Pharmacol. 2021 May 10:12:670224.|Genes Dis. 2024 Mar 8;11 (6) :101262.|Heliyon. 2024 Jan 16;10 (2) :e24602.|Heliyon. 2024 Jul 2;10 (13) :e33936.|Hum Reprod. 2021 Mar 18;36 (4) :951-964.|Inflammation. 2025 May 13.|Int J Biol Macromol. 2022 Mar 31:202:657-670.|Int J Mol Med. 2021 Apr;47 (4) :61.|Int J Mol Med. 2022 Feb;49 (2) :17.|Int J Mol Sci. 2024 Feb 20, 25 (5), 2458.|Int J Mol Sci. 2024 Mar 27;25 (7) :3735.|Int J Mol Sci. 2024 Sep 30;25 (19) :10534.|Int J Pharm. 2019 Dec 15;572:118782.|iScience. 2021 Sep 25;24 (10) :103170.|J Adv Res. 2025 Aug:74:429-442.|J Bone Miner Res. 2020 Jun;35 (6) :1163-1173.|J Cancer Res Clin Oncol. 2024 Sep 23;150 (9) :429.|J Cell Physiol. 2020 Apr;235 (4) :3425-3437.|J Cell Physiol. 2020 Feb;235 (2) :1013-1024.|J Cell Physiol. 2021 Apr;236 (4) :2725-2739.|J Cell Physiol. 2020 Apr;235 (4) :3329-3339.|J Cell Sci. 2022 Aug 1;135 (15) :jcs259090.|J Colloid Interface Sci. 2024 Jan;653 (Pt A) :20-29.|J Ethnopharmacol. 2025 May 27:120055.|J Exp Clin Cancer Res. 2021 Jun 23;40 (1) :206.|J Exp Clin Cancer Res. 2023 Jan 5;42 (1) :5.|J Hazard Mater. 2022 Aug 15;436:129043.|J Immunol Res. 2022 Jun 17:2022:6833867.|J Med Chem. 2019 Oct 10;62 (19) :8760-8772. |J Med Virol. 2024 Oct;96 (10) :e29945.|J Nanobiotechnology. 2025 Feb 14;23 (1) :109.|J Nanobiotechnology. 2025 Oct 16;23 (1) :684.|J Neurosci Res. 2023 Jul;101 (7) :1107-1124.|J Nutr Biochem. 2025 Jun 11:109999.|J Pharm Anal. 2023 Jan;13 (1) :99-109.|J Photochem Photobiol B. 2025 Dec:273:113303.|Lab Invest. 2022 Dec;102 (12) :1323-1334.|Life Sci. 2020 Apr 15;247:117425.|Life Sci. 2020 Nov 1;260:118077.|Light Sci Appl. 2024 Oct 31;13 (1) :304.|mBio. 2025 Mar 24:e0012725.|Mol Cell Proteomics. 2023 Jun;22 (6) :100551.|Mol Med Rep. 2025 Aug;32 (2) :215.|Mol Med. 2024 Jun 12;30 (1) :83.|Mol Med. 2024 Nov 5;30 (1) :199.|Mol Neurobiol. 2025 Jul;62 (7) :9271-9289.|Mol Oncol. 2023 Nov;17 (11) :2451-2471.|Mol Ther Oncol. 2025 Apr 14;33 (2) :200983. |Nanoscale Res Lett. 2021 Feb 23;16 (1) :37.|Nanotoxicology. 2022 Nov-Dec;16 (9-10) :829-843.|Nat Cancer. 2025 May;6 (5) :768-785.|Nat Cell Biol. 2024 Sep;26 (9) :1545-1557.|Nat Commun. 2025 Jan 31;16 (1) :1212.|Neurochem Res. 2024 Jul;49 (7) :1703-1719.|Neuroreport. 2022 Nov 2;33 (16) :705-713.|Neurotherapeutics. 2020 Oct;17 (4) :1796-1812.|Oncol Rep. 2021 Nov;46 (5) :240.|Oxid Med Cell Longev. 2021 Feb 10:2021:6670497.|Oxid Med Cell Longev. 2022 Jan 15:2022:9947191.|Oxid Med Cell Longev. 2022 Jul 5:2022:8983667.|Oxid Med Cell Longev. 2023 Jan 31:2023:1367938.|Pharmacol Res. 2021 Aug:170:105701.|Phytomed Plus. 2023 Aug 25, 100482.|Phytomedicine. 2021 Jan;80:153370.|Phytomedicine. 2021 May:85:153551.|Phytomedicine. 2022 May 13;102:154164.|Phytomedicine. 2024 Oct 26:135:156195.|Phytomedicine. 2025 Apr:139:156465.|Phytomedicine. 2025 Jan 25:139:156417.|Phytomedicine. 2025 May 10:143:156840.|Phytomedicine. 2025 Nov 29:150:157633.|Redox Biol. 2020 Jan;29:101402.|Redox Biol. 2021 Jul;43:101977.|Redox Biol. 2022 Apr;50:102257.|Redox Biol. 2024 Dec 5:79:103460.|Redox Biol. 2024 Nov 5:78:103419.|Reprod Toxicol. 2021 Oct:105:156-165.|Research Square Preprint. 2020 Oct.|Research Square Preprint. 2021 Jan.|Research Square Preprint. 2021 Oct.|Research Square Preprint. 2022 Feb.|Research Square Preprint. 2022 Jan.|Research Square Preprint. 2023 Nov 17.|Research Square Preprint. 2023 Sep 18.|Research Square Print. 2022 Jul.|Research Square Print. 2023 Feb 20.|Sci Adv. 2022 Mar 4;8 (9) :eabm1896.|Sci Adv. 2023 Nov 15;9 (46) :eadf4345.|Sci Rep. 2025 Jan 8;15 (1) :1351.|Sci Total Environ. 2024 Mar 15:916:170342.|Signal Transduct Target Ther. 2020 May 8;5 (1) :51.|SLAS Discov. 2023 Dec 13:100130.|SLAS Discov. 25 October 2021.|SSRN. 2023 Sep 18.|SSRN. 2024 Apr 23.|SSRN. 2025 Aug 21.|SSRN. 2025 Jun 6.|SSRN. 2025 Sep 16.|Surf Interfaces. 2025 Sep 1.|Talanta. 2024 Jun 1:277:126352.|Theranostics. 2020 Apr 6;10 (11) :5107-5119. |Thromb Haemost. 2024 Jun;124 (6) :568-580.|Toxicol Appl Pharmacol. 2025 Oct 4:505:117590.|Toxicology. 2024 Sep 12:509:153938.|Toxicology. 2025 Feb 5:154078.|Toxics. 2024 Aug 31;12 (9) :644.|Vet Microbiol. 2025 Apr 27:305:110538.|World J Diabetes. 2021 Feb 15;12 (2) :124-137.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal HRASLS2 Antibody [Alexa Fluor 750]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
